The aggregation of CD20+ B cells and CD8+ T cells plays a crucial role in the tumour immune response through costimulatory signalling, such as CD40/CD40L, which triggers the tumour-killing effect of T cells [51]. This evidence concerns the gene CD8A and neoplasm.